Jazz Pharmaceuticals plc·4

Jun 7, 7:15 PM ET

Sablich Kim 4

4 · Jazz Pharmaceuticals plc · Filed Jun 7, 2023

Insider Transaction Report

Form 4
Period: 2023-06-05
Sablich Kim
EVP & GM, North America
Transactions
  • Disposition to Issuer

    Ordinary Shares

    2023-06-05$129.73/sh2,082$270,09828,478 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT